Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma
of the Pleura
Background:
Drugs used in chemotherapy use different ways to stop tumor cells from dividing
so they stop growing or die. It is not yet known whether receiving cisplatin with
raltitrexed is more effective than cisplatin alone for malignant mesothelioma. This
is a randomized phase III trial to compare the effectiveness of cisplatin with or
without raltitrexed in treating patients who have malignant mesothelioma of the
pleura.
